United Kingdom-Belfast: Regulatory Peptide Reagent Kits

Type of document: Voluntary ex ante transparency notice
Country: United Kingdom
OJEU Ref: (2018/S 249-575758/EN)
Nature of contract: Supply contract
Procedure: Negotiated without a call for competition
Regulation of procurement: EU – with participation by GPA countries
Type of bid required: Not applicable

Voluntary ex ante transparency notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: Belfast Health nnd Social Care Trust
Postal address: Dorothy Gardiner Unit, Knockbracken Healthcare Park
Town: Belfast
Postal code: BT8 8BH
Country: United Kingdom
Contact Person: Norma Moore
Telephone: +44 2895045210
Email: norma.moore@belfasttrust.hscni.net
Internet address(es):
Main address:
Address of the buyer profile:

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Regulatory Peptide Reagent Kits

Reference number: STA 6785
II.1.2) Main CPV code: 33000000
II.1.3) Type of contract Supplies
II.1.4) Short Description:
Regulatory peptide reagent kits for the monitoring and diagnosis of malignant neuroendocrine tumours.
II.1.6) Information about lots
The contract is divided into lots: no
II.1.7) Total value of the procurement(excluding VAT)
Value:160000.00
Currency:GBP
II.2) Description
II.2.3) Place of performance
Nuts code: UKN0
II.2.4) Description of the procurement
Regulatory peptide reagent kits for the monitoring and diagnosis of malignant neuroendocrine tumours.

II.2.5) Award criteria
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Negotiated procedure without prior publication(in accordance with Article 32 of Directive 2014/24/EU)
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information

Section V: Award of contract/concession
Contract No: STA6785
Title: Regulatory Peptide Reagent Kits for the Monitoring and Diagnosis of Malignant Neuroendocrine Tumours

V.2) Award of contract/concession
V.2.1) Date of conclusion of the contract/concession award decision:2018-12-24
V.2.2) Information about tenders
V.2.3) Name and address of the contractor
Official name: SVAR Life Science AB
Postal address: PO Box 50117
Town: Malmo
Postal code: SE — 202 11
Country: Sweden
Nuts code: SE
Internet address:
The contractor is an SME: no

V.2.4) Information on value of the contract/lot/concession(excluding VAT)
for framework agreements – total maximum value for this lot
for contracts based on framework agreements, if required – value of contract(s) for this lot not included in
previous contract award notices

Section VI: Complementary informationVI.4) Procedures for review
VI.4.1) Review body
Official name: Belfast Health and Social Care Trust
Postal address: Dorothy Gardiner Unit, Knockbracken Healthcare Park
Town: Belfast
Postal code: BT8 8BH
Country: United Kingdom
Telephone: +44 2895045210
E-mail: norma.moore@belfasttrust.hscni.net
Internet address:

VI.5) Date of dispatch of this notice:
2018-12-24

Justification for the award of the contract without prior publication of a call for
competition in the Official Journal of the European Union
1.Justification for the choice of the negotiated procedure without prior publication of a call for competition in accordance with Article
32 of Directive 2014/24/EU
The works, supplies or services can be provided only by a particular economic operator for the following reason:
absence of competition for technical reasons

3.Explanation
Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union
is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive:
These regulatory peptide reagent kits are the only kits that can provide the scope of assays required with the required sensitivity, therefore competition is absent for technical reasons and no other reasonable alternative exists.